Nirogy Therapeutics

About:

Nirogy Therapeutics is focusing on small-molecule drugs that target the solute carrier family of transporter proteins (SLCTs).

Website: https://nirogytx.com/

Twitter/X: nirogyonetx

Top Investors: Sporos Bioventures, Sante Ventures

Description:

Nirogy Therapeutics is a biotechnology company developing novel small molecules to target cellular transporters. The company is currently advancing a class of small molecules intended to disrupt metabolic and immune mechanisms operative in the tumor microenvironment. Follow-on platform programs are targeting additional disease pathways in oncology as well as autoimmune diseases.